Location History:
- Canicatti′, IT (2022)
- Canicatti, IT (2023)
Company Filing History:
Years Active: 2022-2023
Title: **Clara La Marca: Innovator in Ocular Disease Treatment**
Introduction
Clara La Marca, an inventive mind based in Canicatti′, Italy, has made significant strides in the field of ocular health. With a focus on nanostructured formulations, she has contributed to advancements that hold the potential to transform treatment methods for ocular diseases. La Marca holds two patents that underscore her innovative approach to combating neurodegenerative ocular conditions.
Latest Patents
Clara La Marca's latest patents revolve around the development of nanostructured formulations for the effective delivery of silibinin and other active ingredients intended for treating ocular diseases. These formulations include lipid nanoparticle systems of the SLN (Solid Lipid Nanoparticles) and NLC (Nanostructured Lipid Carriers) type. They utilize calixarenes that may possess mucoadhesive properties, as well as micellar and nanoparticle systems crafted from amphiphilic inulin copolymers. The versatility of calixarene compounds is emphasized, highlighting their ability to load and release active ingredients that typically exhibit low water solubility, alongside challenges related to chemical degradation and bioavailability. These innovations are poised to enhance treatments for ocular diseases, particularly neurodegenerative ailments.
Career Highlights
Clara La Marca is affiliated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where her research focuses on harnessing advanced materials to address complex health issues. Through her work, she has established herself as a pivotal figure in the field of ocular therapeutic innovations. Her commitment to research and advancement in this specialized area demonstrates a deep understanding of both the practical and theoretical aspects of medical applications.
Collaborations
Throughout her career, La Marca has collaborated with notable peers, including Anna Rita Blanco and Gennara Cavallaro. These collaborations are integral to her research, fostering an environment of shared knowledge and innovation that further drives the development of her patented formulations.
Conclusion
Clara La Marca represents the future of ocular disease treatment with her groundbreaking formulations and dedication to research. Her patents not only showcase her ingenuity but also reflect a commitment to improving patient outcomes through innovative therapeutic strategies. With a strong foundation in collaboration and research, La Marca's contributions continue to inspire advancements in ocular health technologies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.